Inflammation plays a central role in the aetiology of many immunologically related diseases, such as infectious disease, osteoarthritis and respiratory disease, as well as neurologic, metabolic and cardiovascular disease and cancer.
New Merck MILLIPLEX® MAP Human Cancer Autoantibody Panel, a 15-plex customisable panel.
For over ten years, Merck have offered the benefits of MILLIPLEX® map multiplexed assay panels—containing all the components and reagents you need to detect multiple analytes simultaneously.
The MILLIPLEX® MAP RTK Phosphoprotein Magnetic Bead Customizable Panel is used to detect changes in phosphorylated (panTyr) c-Kit, c-Met/HGFR, EGFR, ErbB2/HER2, ErbB3/HER3 , ErbB4/HER4 , FGFR1 , FLT3 , IGF-1R, IR, M-CSFR, PDGFRα, PDGFRβ, TIE1, TIE2, VEGFR1, VEGFR2, and VEGFR3 in cell lysates using the Luminex® system.
The Human Diabetes Premixed Panel (Cat# HDIAB-34K-PMX5) is now available.
MERCK APPLICATION NOTES